Trump signs order to accelerate access to psychedelic drug treatments

President Trump signed an executive order to expedite the review of psychedelic drugs like ibogaine, which has gained support from combat veterans and conservative lawmakers despite known safety risks. The move aims to accelerate access to these treatments, though concerns about their potential dangers remain.